Rallybio Stock Gains 19% Over Merger Agreement With Avenzo Therapeutics
AI disclosure
Summary
Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therape...